5 completed, 3 recruiting, 2 active not recruiting, 1 unknown. 4 Not applicable, 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Contrast: new trials by email Literature Review of Contrast trials Research Report on Contrast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer Biospecimen Collection, Contrast Agent, Leuprolide - Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | Phase 2 | Recruiting | Ohio State University Comprehensive Cancer Center | 70 | 2024-08-12 | 2026-03-09 |
| Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications Biospecimen Collection, Contrast Agent, Contrast-Enhanced Mammography - Breast Carcinoma | Active not recruiting | M.D. Anderson Cancer Center | 59 | 2021-03-23 | 2026-08-12 | |
| Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer Computed Tomography, Contrast Agent - Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Not applicable | Active not recruiting | Rutgers, The State University of New Jersey | 34 | 2021-02-11 | 2026-06-11 |
| Effect of Evolocumab on Coronary Atherosclerosis Evolocumab, 18F-NaF PET, CCTA - Cardiovascular Disease, Hyperlipidemia | Phase 3 | Completed | Cedars-Sinai Medical Center | 55 | 2019-03-19 | 2024-07-17 |
| Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors Contrast Agent, Magnetic Resonance Imaging, Quality-of-Life Assessment - Malignant Oral Cavity Neoplasm, Malignant Skull Base Neoplasm | Phase 4 | Recruiting | M.D. Anderson Cancer Center | 425 | 2018-09-17 | 2026-05-22 |
| Coronary Atherosclerosis T1-Weighted Characterization (CATCH) Cardiac MRI, Contrast, Beta blocker - Coronary Atherosclerosis | Not applicable | Recruiting | Cedars-Sinai Medical Center | 150 | 2018-07-30 | 2026-08-21 |
| Whole-Heart Myocardial Blood Flow Quantification Using MRI Myocardial Perfusion Cardiac MRI., Contrast, Pharmacologic Stress Agent - Coronary Artery Disease, Coronary Microvascular Disease | Unknown | Cedars-Sinai Medical Center | 160 | 2018-03-01 | 2023-02-08 | |
| Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer Contrast Agent, Digital Tomosynthesis Mammography, Dual-Energy Contrast-Enhanced Digital Spectral Mammography - Breast Carcinoma | Not applicable | Completed | University of Southern California | 43 | 2017-04-21 | 2021-11-18 |
| DYNA EMBOLIZATION - Pilot Study of IV Dyna CT and CBV Imaging Techniques Contrast - Brain Lesions | Not applicable | Completed | Medical University of South Carolina | 30 | 2015-07-01 | 2021-02-01 |
| Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial contrast - Contrast Induced Nephropathy | Completed | Sun Yat-sen University | 592 | 2013-10-01 | 2016-01-08 | |
| A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT) regadenoson, technetium Tc99m sestamibi /technetium Tc99m tetrafosmin, Contrast - Coronary Artery Disease (CAD) | Phase 2 | Completed | Astellas Pharma Inc | 124 | 2011-04-26 | 2024-12-04 |
Coronary Artery Disease (3) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Cardiovascular Diseases (1) · Hyperlipidemias (1) · Ischemia (1) · Lung Neoplasms (1) · Microvascular Angina (1) · Mouth Neoplasms (1) · Osteoradionecrosis (1) · Prostatic Neoplasms (1)
Cedars-Sinai Medical Center (3) · M.D. Anderson Cancer Center (2) · Astellas Pharma Inc (1) · Medical University of South Carolina (1) · Ohio State University Comprehensive Cancer Center (1) · Rutgers, The State University of New Jersey (1) · Sun Yat-sen University (1) · University of Southern California (1)
United States (10) · China (1)
Daniel S. Berman, MD (1) · Debiao Li, PhD (1) · Mary Yamashita, MD (1) · Olena Weaver (1) · Salma K Jabbour, MD (1) · Shang-Jui Wang, MD, PhD (1) · Stephen Y Lai (1) · Zhaoyang Fan, PhD (1)
P30CA014089 (1), P30CA072720 (1), R01HL124649 (1)